Functional analysis of pRb2/p130 interaction with cyclins.
暂无分享,去创建一个
A. Giordano | P. Claudio | C. Howard | A. Baldi | A. Luca | M. G. Paggi | E. Firpo | A. Koff | A. Giordano | A. de Luca | A. Baldi
[1] A. Giordano,et al. Genomic structure of the human retinoblastoma-related Rb2/p130 gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[2] N. Penneys. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene , 1996 .
[3] M. Stratton,et al. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12–q13: evidence for its role as a tumour suppressor gene , 1995, Nature Genetics.
[4] D. Johnson,et al. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. , 1995, Oncogene.
[5] W. Cance,et al. The nuclear tyrosine kinase Rak associates with the retinoblastoma protein pRb. , 1995, Cancer research.
[6] J. Bartek,et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 , 1995, Nature.
[7] R. Kerkhoven,et al. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. , 1995, Genes & development.
[8] E. Harlow,et al. The pRB‐related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. , 1995, The EMBO journal.
[9] D. Livingston,et al. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. , 1995, Genes & development.
[10] R. Weinberg,et al. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[11] K. Scheidtmann,et al. p53 phosphorylation mutants retain transcription activity. , 1995, Oncogene.
[12] J. Nevins,et al. The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2 , 1995, Molecular and cellular biology.
[13] G. Condorelli,et al. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. , 1994, Cancer research.
[14] A. Bowcock,et al. Two novel human serine/threonine kinases with homologies to the cell cycle regulating Xenopus MO15, and NIMA kinases: cloning and characterization of their expression pattern. , 1994, Oncogene.
[15] K. Klinga-Levan,et al. The retinoblastoma-related gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. , 1993, Oncogene.
[16] A. Duncan,et al. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. , 1993, Genes & development.
[17] G. Hannon,et al. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. , 1993, Genes & development.
[18] A. Giordano,et al. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. , 1993, Oncogene.
[19] D. Livingston,et al. Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F , 1993, Molecular and cellular biology.
[20] M. Ewen,et al. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. , 1993, Genes & development.
[21] S. Hiebert. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression , 1993, Molecular and cellular biology.
[22] R. Weinberg,et al. Physical interaction of the retinoblastoma protein with human D cyclins , 1993, Cell.
[23] David M. Livingston,et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.
[24] D. Templeton,et al. Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding , 1992, Molecular and cellular biology.
[25] R. Weinberg,et al. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins , 1992, Cell.
[26] James M. Roberts,et al. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle , 1992 .
[27] W. Kaelin,et al. Identification of a growth suppression domain within the retinoblastoma gene product. , 1992, Genes & development.
[28] John Calvin Reed,et al. Cell cycle analysis of p26-BCL-2 protein levels in proliferating lymphoma and leukemia cell lines. , 1992, Cancer research.
[29] D. Livingston,et al. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Nevins,et al. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. , 1992, Genes & development.
[31] M. Ewen,et al. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner , 1992, Cell.
[32] M. Ewen,et al. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein , 1991, Cell.
[33] Joseph R. Nevins,et al. The E2F transcription factor is a cellular target for the RB protein , 1991, Cell.
[34] E. Harlow,et al. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle , 1989, Cell.
[35] Phang-lang Chen,et al. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation , 1989, Cell.
[36] B. Franza,et al. A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells , 1989, Cell.
[37] E. Surmacz,et al. Gene transfer: DNA microinjection compared with DNA transfection with a very high efficiency. , 1982 .
[38] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[39] A. Giordano,et al. Neoplastic Transformation: Oncogenes, Tumor Suppressors, Cyclins, and Cyclin-Dependent Kinases , 1996 .
[40] W. Cavenee,et al. Loss of constitutional heterozygosity in human cancer. , 1991, Annual review of genetics.
[41] A. Giordano,et al. PITALRE , a nuclear CDC 2-related protein kinase that phosphorylates the retinoblastoma protein in vitro ( cell division cycle 2 / cydin-dependent kinase / myelin badc protein / sere-threonine protein kinase ) , 2022 .